Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

jbog,

I understand patients don't like to change drugs and want a cheaper drug.

What I don't understand is what is our current production capacity. It could well be limited early on in production. That could be a reason the drug is being priced higher right now. Remember each prescription is 30 doses. 30K injections prescribed a week and growing.

Does MNTA want to meet a certain income level before easing back on the price?

I am not Sandoz and don't know all the details why. We will likely get more input shortly on the next conference call at the end of this quarter.

Why don't you and Tony ask questions on the CC?

Boing X 2